Clinical Trials
44 trialsTumor Related Epilepsy
National Institutes of Health Clinical Center (CC)
EpiCom
Jazz Pharmaceuticals
Glioblastoma Remote Monitoring and Care - Research Protocol
Case Comprehensive Cancer Center
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment
Novartis
Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases
Brigham and Women's Hospital
EpiTALY
Jazz Pharmaceuticals
LIBRA
Tata Memorial Centre
Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures
Jazz Pharmaceuticals
Mapping of Human Cognition
The University of Texas Health Science Center, Houston
Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC
Noema Pharma AG
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Celgene
STAMP
Beijing Tiantan Hospital
SURF-ROGG
University Hospital Schleswig-Holstein
UPWARD
Astellas Pharma Inc
LeviTaTe Pilot
Hamilton Health Sciences Corporation
Effect of Perampanel on Peritumoral Hyperexcitability in HGG
Dana-Farber Cancer Institute
Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery
Konkuk University Medical Center
PTN_POPS
Duke University
Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity
Azienda Sanitaria-Universitaria Integrata di Udine
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Quadriga Biosciences, Inc.
A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
Jazz Pharmaceuticals
An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
Jazz Pharmaceuticals
Hypovitaminosis D in Neurocritical Patients
University of Utah
OMNI-Can
OMNI Medical Services, LLC
Neurology Inpatient Clinical Education Trial
Dartmouth-Hitchcock Medical Center
1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients
University of Florida
ELEKTRA
Takeda
AEO
MetVital, Inc.
Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Peking Union Medical College Hospital
Our Anesthesia Experience During MRI Scan
Akdeniz University
The NEUROlogically-impaired Extubation Timing Trial (NEURO-ETT)
Sunnybrook Health Sciences Centre
NEURO-ETT
Sunnybrook Health Sciences Centre
CRESS
Beijing Tiantan Hospital
Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo
Beth Israel Deaconess Medical Center
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
University of Alabama at Birmingham
Turmeric as Treatment in Epilepsy
NYU Langone Health
Perampanel in Seizure Patients With Primary Glial Brain Tumors
Duke University
MAGNA
Fundacion Clinic per a la Recerca Biomédica
STARS
University of Pennsylvania
Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis
National Institutes of Health Clinical Center (CC)
EXIST-2
Novartis
Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery
Radiation Therapy Oncology Group
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors
Centre Hospitalier Universitaire Vaudois
Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases
Northwestern University